Log in

NASDAQ:PRAHPRA Health Sciences Earnings Date, Estimates & History

+0.77 (+0.80 %)
(As of 05/25/2020 04:00 PM ET)
Today's Range
Now: $97.46
50-Day Range
MA: $89.03
52-Week Range
Now: $97.46
Volume192,511 shs
Average Volume477,520 shs
Market Capitalization$6.21 billion
P/E Ratio26.63
Dividend YieldN/A


PRA Health Sciences (NASDAQ:PRAH) Earnings Information

PRA Health Sciences last released its quarterly earnings data on April 30th, 2020. The medical research company reported $1.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.01 by $0.04. The firm earned $783.71 million during the quarter, compared to analysts' expectations of $749.61 million. Its revenue for the quarter was up 8.5% on a year-over-year basis. PRA Health Sciences has generated $4.80 earnings per share over the last year and currently has a price-to-earnings ratio of 26.6. PRA Health Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 29th, 2020 based off prior year's report dates.

PRA Health Sciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRA Health Sciences (NASDAQ:PRAH) Earnings Estimates

2020 EPS Consensus Estimate: $3.82
2021 EPS Consensus Estimate: $5.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202$0.89$0.91$0.90
Q2 20203$0.62$0.89$0.73
Q3 20204$0.76$1.11$0.94
Q4 20204$1.02$1.44$1.26
Q1 20211$1.18$1.18$1.18
Q2 20211$1.29$1.29$1.29
Q3 20211$1.34$1.34$1.34
Q4 20211$1.39$1.39$1.39

PRA Health Sciences (NASDAQ PRAH) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/30/20203/31/2020$1.01$1.05$1.11$749.61 million$783.71 millionTranscript
2/20/2020Q4$1.32$1.54$1.68$794.91 million$800.24 millionTranscript
10/30/2019Q3 2019$1.29$1.32$1.13$771.64 million$780.70 millionTranscript
7/31/2019Q2$1.11$1.22$1.54$764.95 million$763.31 millionListen
5/1/20193/31/2019$0.95$1.10$1.32$730.84 million$722.00 millionListen
2/27/2019Q4 2018$1.18$1.21$1.35$750.67 million$729.65 millionN/A
10/31/20189/30/2018$1.07$1.13$2.04$729.63 million$717.60 millionN/A
8/1/2018Q2 2018$0.88$1.00$1.20$706.57 million$722.84 millionN/A
4/25/2018Q1 2018$0.84$0.85$0.97$694.73 million$701.80 millionN/A
2/21/2018Q4 2017$1.02$1.04$2.33$543.78 million$568.80 millionN/A
10/25/2017Q3 2017$0.85$0.88$0.91$477.89 million$494.55 millionN/A
8/7/2017Q2 2017$0.72$0.62$0.79$447.79 million$457.90 millionListen
4/25/2017Q1 2017$0.58$0.60$0.81$426.81 million$427.08 millionN/A
2/22/2017Q4 2016$0.64$0.68$1.14$405.04 million$413.61 millionN/A
11/2/2016Q3 2016$0.62$0.62$0.75$394.87 million$399.80 millionN/A
7/28/2016Q2 2016$0.58$0.61$0.62$381.25 million$394.20 millionListen
4/27/2016Q1 2016$0.50$0.53$1.33$372.21 million$372.30 millionListen
2/24/2016Q4 2015$0.48$0.57$0.69$353.42 million$428.90 millionListen
11/2/2015Q3 2015$0.41$0.50$0.63$346.05 million$345.10 millionListen
7/27/2015Q2 2015$0.37$0.43$0.66$336.74 million$336.50 millionListen
5/6/2015Q1 2015$0.31$0.40$0.53$329.80 million$332.00 millionListen
2/18/2015Q4 2014$0.31$0.34$1.13$323.50 million$370.00 millionListen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.